A Comprehensive Review of Viral Characteristics, Transmission, Pathophysiology, Immune Response, and Management of SARS-CoV-2 and COVID-19 as a Basis for Controlling the Pandemic

Frontiers in Immunology, Journal Year: 2021, Volume and Issue: 12

Published: Feb. 26, 2021

COVID-19 emerged from China in December 2019 and during 2020 spread to every continent including Antarctica. The coronavirus, SARS-CoV-2, has been identified as the causative pathogen, its stretched capacities of healthcare systems negatively affected global economy. This review provides an update on virus, genome, risks associated with emergence variants, mode transmission, immune response, children elderly, advances made contain, prevent manage disease. Although our knowledge mechanics virus transmission response substantially demystified, concerns over reinfection, susceptibility elderly whether asymptomatic promote remain unanswered. There are also uncertainties about pathophysiology why there variations clinical presentations some patients suffer long lasting symptoms—“ haulers .” To date, no significantly effective curative drugs for COVID-19, especially after failure hydroxychloroquine trials produce positive results. RNA polymerase inhibitor, remdesivir, facilitates recovery severely infected cases but, unlike anti-inflammatory drug, dexamethasone, does not reduce mortality. However, vaccine development witnessed substantial progress several being approved countries around globe.

Language: Английский

DFT and MD simulation investigation of favipiravir as an emerging antiviral option against viral protease (3CLpro) of SARS-CoV-2

Journal of Molecular Structure, Journal Year: 2021, Volume and Issue: 1246, P. 131253 - 131253

Published: Aug. 6, 2021

Language: Английский